LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisitions Iktos Inc. recently acquired Synsight, a French biotech company applying AI to the discovery of novel drug candidates. This acquisition presents an opportunity to upsell AI and robotics solutions for new drug design to more clients in the biotech industry.

Industry Partnerships By partnering with companies like Elsevier and Nerviano Medical Sciences S.r.l., Iktos Inc. is expanding its reach and credibility in the AI-driven drug discovery space. Leveraging these partnerships can open doors for collaborative sales efforts and joint ventures.

Sustainable Product Development With a focus on developing sustainable crop protection products in collaboration with Bayer's Crop Science division, Iktos Inc. is tapping into the growing market demand for environmentally-friendly solutions. Leveraging this sustainable product portfolio can attract customers seeking eco-friendly options.

Recognitions and Awards By winning the 'Big Data & AI for Good' prize and receiving recognition at industry events like the Big Data & AI Paris Congress, Iktos Inc. is establishing itself as a leader in AI-driven innovation. Highlighting these achievements in sales pitches can enhance brand reputation and credibility.

Funding and Growth With a recent funding round of $15.5 million led by Merck Ventures and Debiopharm Innovation, Iktos Inc. has the financial backing to scale its operations and expand market presence. This financial stability can be highlighted to instill confidence in potential clients and investors.

Similar companies to iktos

iktos Tech Stack

iktos uses 8 technology products and services including React, jQuery Migrate, RSS, and more. Explore iktos's tech stack below.

  • React
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • RSS
    Miscellaneous
  • Vercel
    Platform As A Service
  • Node.js
    Programming Languages
  • PHP
    Programming Languages
  • YouTube
    Video Players
  • OpenSSL
    Web Server Extensions

Media & News

iktos's Email Address Formats

iktos uses at least 1 format(s):
iktos Email FormatsExamplePercentage
First.Last@iktos.aiJohn.Doe@iktos.ai
48%
First@iktos.aiJohn@iktos.ai
3%
First.MiddleLast@iktos.aiJohn.MichaelDoe@iktos.ai
1%
First.Last@iktos.aiJohn.Doe@iktos.ai
48%

Frequently Asked Questions

Where is iktos's headquarters located?

Minus sign iconPlus sign icon
iktos's main headquarters is located at 65, Rue de Prony Paris, Île-de-France 75017 FR. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is iktos's official website and social media links?

Minus sign iconPlus sign icon
iktos's official website is iktos.ai and has social profiles on LinkedIn.

How much revenue does iktos generate?

Minus sign iconPlus sign icon
As of September 2024, iktos's annual revenue reached $15M.

What is iktos's SIC code NAICS code?

Minus sign iconPlus sign icon
iktos's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does iktos have currently?

Minus sign iconPlus sign icon
As of September 2024, iktos has approximately 85 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: S. M.Head Of Ai & Data: H. T.Head Of Engineering: C. T.. Explore iktos's employee directory with LeadIQ.

What industry does iktos belong to?

Minus sign iconPlus sign icon
iktos operates in the Biotechnology Research industry.

What technology does iktos use?

Minus sign iconPlus sign icon
iktos's tech stack includes ReactjQuery MigrateRSSVercelNode.jsPHPYouTubeOpenSSL.

What is iktos's email format?

Minus sign iconPlus sign icon
iktos's email format typically follows the pattern of . Find more iktos email formats with LeadIQ.

How much funding has iktos raised to date?

Minus sign iconPlus sign icon
As of September 2024, iktos has raised $16M in funding. The last funding round occurred on Mar 09, 2023 for $16M.

When was iktos founded?

Minus sign iconPlus sign icon
iktos was founded in 2016.
iktos

iktos

Biotechnology ResearchÎle-de-France, France51-200 Employees

We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization.

Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity.

Please visit our webpage to know more about our products and offerings 
https://iktos.ai/products/

Section iconCompany Overview

Headquarters
65, Rue de Prony Paris, Île-de-France 75017 FR
Website
iktos.ai
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $16M

    iktos has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Mar 09, 2023 in the amount of $16M.

  • $10M$50M

    iktos's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $16M

    iktos has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Mar 09, 2023 in the amount of $16M.

  • $10M$50M

    iktos's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.